Familial cardiomyopathy with thickening of left ventricular (LV) myocardium without other cardiac or systemic disease; typically involves ventricular septum
IMAGING
General Features
Radiographic Findings
MR Findings
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Staging, Grading, & Classification
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
Selected References
Pleva M et al: [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part II.] Vnitr Lek. 63(4):249-53, Spring
Huang G et al: Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation". Int J Cardiovasc Imaging. 36(3):553-61, 2020
Tower-Rader A et al: Multimodality imaging in hypertrophic cardiomyopathy for risk stratification. Circ Cardiovasc Imaging. 13(2):e009026, 2020
Guido V et al: [Role of multimodality imaging in the clinical evaluation of hypertrophic cardiomyopathy.] G Ital Cardiol (Rome). 20(12):746-61, 2019
Makavos G et al: Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment. Heart Fail Rev. 24(4):439-59, 2019
Kamal MU et al: Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: current state of the art. Cardiol J. 23(3):250-63, 2016
Authors/Task Force members et al: 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 35(39):2733-79, 2014
Bogaert J et al: MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology. 273(2):329-48, 2014
Desai MY et al: Cardiac magnetic resonance in hypertrophic cardiomyopathy. Curr Cardiol Rep. 13(1):67-76, 2011
Familial cardiomyopathy with thickening of left ventricular (LV) myocardium without other cardiac or systemic disease; typically involves ventricular septum
IMAGING
General Features
Radiographic Findings
MR Findings
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Staging, Grading, & Classification
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
Selected References
Pleva M et al: [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part II.] Vnitr Lek. 63(4):249-53, Spring
Huang G et al: Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation". Int J Cardiovasc Imaging. 36(3):553-61, 2020
Tower-Rader A et al: Multimodality imaging in hypertrophic cardiomyopathy for risk stratification. Circ Cardiovasc Imaging. 13(2):e009026, 2020
Guido V et al: [Role of multimodality imaging in the clinical evaluation of hypertrophic cardiomyopathy.] G Ital Cardiol (Rome). 20(12):746-61, 2019
Makavos G et al: Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment. Heart Fail Rev. 24(4):439-59, 2019
Kamal MU et al: Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: current state of the art. Cardiol J. 23(3):250-63, 2016
Authors/Task Force members et al: 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 35(39):2733-79, 2014
Bogaert J et al: MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology. 273(2):329-48, 2014
Desai MY et al: Cardiac magnetic resonance in hypertrophic cardiomyopathy. Curr Cardiol Rep. 13(1):67-76, 2011
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.